Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study)

BACKGROUND: The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors were confirmed by several clinical trials, but its effectiveness in routine clinical practice in China has not been evaluated. This study aims to describe the real world effectiveness of PCSK-9 i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Geriatr Cardiol
Main Authors: LIU, Yu-Qi, LI, Dan-Dan, CHAI, Meng, CONG, Hong-Liang, CONG, Xiao-Qiang, DAI, Jun, DU, Rong-Pin, GAO, Ming, GUO, Jin-Cheng, GUO, Yan-Qing, HONG, Xiao-Jian, HUANG, Rong-Chong, JIA, Feng-Shun, LI, Jia-Yu, LI, Qing, LIU, Jia-Mei, LIU, Xin-Ping, LIU, Yu-Guo, NIE, Hong-Gang, SHAO, Bing, SHEN, Xiao-Yu, SONG, Hai-Qing, SONG, Yi-Jun, WANG, Li-Jun, WANG, Shuo, WU, Dong-Mei, XIA, Jing, YANG, Zhi-Yong, YU, Hong-Ying, ZHANG, Hui, ZHANG, Tie-Mei, ZHAO, Ji-Yi, ZHAO, Liang-Chen, ZHENG, Ming-Qi, CHEN, Yun-Dai
Formato: Artigo
Idioma:Inglês
Publicado em: Science Press 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100428/
https://ncbi.nlm.nih.gov/pubmed/33995505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11909/j.issn.1671-5411.2021.04.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados